KLS
2021-07-02
Buybuy
EQT, Goldman near $9 bln deal to buy contract research firm Parexel - WSJ
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
4
5
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":156175493,"tweetId":"156175493","gmtCreate":1625206515612,"gmtModify":1633942534543,"author":{"id":3551655093075927,"idStr":"3551655093075927","authorId":3551655093075927,"authorIdStr":"3551655093075927","name":"KLS","avatar":"https://static.tigerbbs.com/60fe00969bbce4cfecf0d17a38c77628","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":57,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Buybuy</p></body></html>","htmlText":"<html><head></head><body><p>Buybuy</p></body></html>","text":"Buybuy","highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":4,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/156175493","repostId":2148820073,"repostType":4,"repost":{"id":"2148820073","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1625206095,"share":"https://www.laohu8.com/m/news/2148820073?lang=&edition=full","pubTime":"2021-07-02 14:08","market":"us","language":"en","title":"EQT, Goldman near $9 bln deal to buy contract research firm Parexel - WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2148820073","media":"Reuters","summary":"July 1 (Reuters) - Private equity firm EQT AB and Goldman Sachs Group's investment arm are in advanc","content":"<p>July 1 (Reuters) - Private equity firm <a href=\"https://laohu8.com/S/EQBBF\">EQT AB</a> and Goldman Sachs Group's investment arm are in advanced talks to buy contract research company Parexel International Corp for nearly $9 billion including debt, the Wall Street Journal reported.</p>\n<p>The sale to EQT and Goldman could be completed this week, the report said on Thursday, citing people familiar with the matter.</p>\n<p>EQT and Goldman Sachs did not immediately respond to Reuters' requests for comment outside business hours, while Parexel could not be reached.</p>\n<p>The news came two weeks after the private equity firm sold Moderna Inc's supplier Aldevron for about $9.6 billion.</p>\n<p>Parexel, which conducts clinical trials for drugmakers to make drug approval procedures easier, had drawn interest from both private equity and strategic bidders, the report said.</p>\n<p>Contract research organizations were hit last year as the COVID-19 pandemic disrupted clinical trials, but they are now seeing a resurgence in demand as drugmakers and governments invest in newer treatments.</p>\n<p>In April, medical device maker Thermo Fisher Scientific Inc agreed to acquire contract researcher PPD Inc for $17.4 billion.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EQT, Goldman near $9 bln deal to buy contract research firm Parexel - WSJ</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEQT, Goldman near $9 bln deal to buy contract research firm Parexel - WSJ\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-02 14:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>July 1 (Reuters) - Private equity firm <a href=\"https://laohu8.com/S/EQBBF\">EQT AB</a> and Goldman Sachs Group's investment arm are in advanced talks to buy contract research company Parexel International Corp for nearly $9 billion including debt, the Wall Street Journal reported.</p>\n<p>The sale to EQT and Goldman could be completed this week, the report said on Thursday, citing people familiar with the matter.</p>\n<p>EQT and Goldman Sachs did not immediately respond to Reuters' requests for comment outside business hours, while Parexel could not be reached.</p>\n<p>The news came two weeks after the private equity firm sold Moderna Inc's supplier Aldevron for about $9.6 billion.</p>\n<p>Parexel, which conducts clinical trials for drugmakers to make drug approval procedures easier, had drawn interest from both private equity and strategic bidders, the report said.</p>\n<p>Contract research organizations were hit last year as the COVID-19 pandemic disrupted clinical trials, but they are now seeing a resurgence in demand as drugmakers and governments invest in newer treatments.</p>\n<p>In April, medical device maker Thermo Fisher Scientific Inc agreed to acquire contract researcher PPD Inc for $17.4 billion.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"EQT":"EQT能源","GS":"高盛"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2148820073","content_text":"July 1 (Reuters) - Private equity firm EQT AB and Goldman Sachs Group's investment arm are in advanced talks to buy contract research company Parexel International Corp for nearly $9 billion including debt, the Wall Street Journal reported.\nThe sale to EQT and Goldman could be completed this week, the report said on Thursday, citing people familiar with the matter.\nEQT and Goldman Sachs did not immediately respond to Reuters' requests for comment outside business hours, while Parexel could not be reached.\nThe news came two weeks after the private equity firm sold Moderna Inc's supplier Aldevron for about $9.6 billion.\nParexel, which conducts clinical trials for drugmakers to make drug approval procedures easier, had drawn interest from both private equity and strategic bidders, the report said.\nContract research organizations were hit last year as the COVID-19 pandemic disrupted clinical trials, but they are now seeing a resurgence in demand as drugmakers and governments invest in newer treatments.\nIn April, medical device maker Thermo Fisher Scientific Inc agreed to acquire contract researcher PPD Inc for $17.4 billion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":14,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":6,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/156175493"}
精彩评论